177 related articles for article (PubMed ID: 32485357)
1. Sublingual dendritic cells targeting by aptamer: Possible approach for improvement of sublingual immunotherapy efficacy.
Keshavarz Shahbaz S; Varasteh AR; Koushki K; Ayati SH; Mashayekhi K; Sadeghi M; Moghadam M; Sankian M
Int Immunopharmacol; 2020 Aug; 85():106603. PubMed ID: 32485357
[TBL] [Abstract][Full Text] [Related]
2. Immune responses modulation by curcumin and allergen encapsulated into PLGA nanoparticles in mice model of rhinitis allergic through sublingual immunotherapy.
Shahgordi S; Sankian M; Yazdani Y; Mashayekhi K; Hasan Ayati S; Sadeghi M; Saeidi M; Hashemi M
Int Immunopharmacol; 2020 Jul; 84():106525. PubMed ID: 32361190
[TBL] [Abstract][Full Text] [Related]
3. DC-targeted gold nanoparticles as an efficient and biocompatible carrier for modulating allergic responses in sublingual immunotherapy.
Sadeghi M; Koushki K; Mashayekhi K; Ayati SH; Keshavarz Shahbaz S; Moghadam M; Sankian M
Int Immunopharmacol; 2020 Sep; 86():106690. PubMed ID: 32585607
[TBL] [Abstract][Full Text] [Related]
4. Use of Polymeric Nanoparticle Platform Targeting the Liver To Induce Treg-Mediated Antigen-Specific Immune Tolerance in a Pulmonary Allergen Sensitization Model.
Liu Q; Wang X; Liu X; Kumar S; Gochman G; Ji Y; Liao YP; Chang CH; Situ W; Lu J; Jiang J; Mei KC; Meng H; Xia T; Nel AE
ACS Nano; 2019 Apr; 13(4):4778-4794. PubMed ID: 30964276
[TBL] [Abstract][Full Text] [Related]
5. A Dendritic Cells-Targeting Nano-Vaccine by Coupling Polylactic-Co-Glycolic Acid-Encapsulated Allergen with Mannan Induces Regulatory T Cells.
Wen H; Qu L; Zhang Y; Xu B; Ling S; Liu X; Luo Y; Huo D; Li W; Yao X
Int Arch Allergy Immunol; 2021; 182(9):777-787. PubMed ID: 34289474
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of Th2 immune responses by sublingual administration of poly (lactic-co-glycolic) acid (PLGA)-encapsulated allergen in BALB/c mice.
Salari F; Varasteh AR; Vahedi F; Hashemi M; Sankian M
Int Immunopharmacol; 2015 Dec; 29(2):672-678. PubMed ID: 26404189
[TBL] [Abstract][Full Text] [Related]
7. Angelica sinensis polysaccharide encapsulated into PLGA nanoparticles as a vaccine delivery and adjuvant system for ovalbumin to promote immune responses.
Gu P; Liu Z; Sun Y; Ou N; Hu Y; Liu J; Wu Y; Wang D
Int J Pharm; 2019 Jan; 554():72-80. PubMed ID: 30399435
[TBL] [Abstract][Full Text] [Related]
8. Dc-specific aptamer decorated gold nanoparticles: A new attractive insight into the nanocarriers for allergy epicutaneous immunotherapy.
Koushki K; Varasteh AR; Shahbaz SK; Sadeghi M; Mashayekhi K; Ayati SH; Moghadam M; Sankian M
Int J Pharm; 2020 Jun; 584():119403. PubMed ID: 32387307
[TBL] [Abstract][Full Text] [Related]
9. A20-OVA Nanoparticles Inhibit Allergic Asthma in a Murine Model.
Luo XQ; Zhong JW; Qiu SY; Zhi M; Yang LQ; Zhou YL; Zhou FX; Yang PC; Liu DB; Mo LH
Inflammation; 2020 Jun; 43(3):953-961. PubMed ID: 31938979
[TBL] [Abstract][Full Text] [Related]
10. Immune response modulation by allergen loaded into mesenchymal stem cell-derived exosomes as an effective carrier through sublingual immunotherapy.
Dehnavi S; Khodadadi A; Asadirad A; Ghadiri AA
Immunobiology; 2023 May; 228(3):152361. PubMed ID: 36870143
[TBL] [Abstract][Full Text] [Related]
11. Polymer nanoparticles for cross-presentation of exogenous antigens and enhanced cytotoxic T-lymphocyte immune response.
Song C; Noh YW; Lim YT
Int J Nanomedicine; 2016; 11():3753-64. PubMed ID: 27540289
[TBL] [Abstract][Full Text] [Related]
12. Light-triggered OVA release based on CuS@poly(lactide-co-glycolide acid) nanoparticles for synergistic photothermal-immunotherapy of tumor.
Chen Z; Zhang Q; Zeng L; Zhang J; Liu Z; Zhang M; Zhang X; Xu H; Song H; Tao C
Pharmacol Res; 2020 Aug; 158():104902. PubMed ID: 32417504
[TBL] [Abstract][Full Text] [Related]
13. Sublingual administration of liposomes enclosing alpha-galactosylceramide as an effective adjuvant of allergen immunotherapy in a murine model of allergic rhinitis.
Suzuki S; Sakurai D; Sakurai T; Yonekura S; Iinuma T; Okuma Y; Ihara F; Arai T; Hanazawa T; Fukuda-Kawaguchi E; Ishii Y; Okamoto Y
Allergol Int; 2019 Jul; 68(3):352-362. PubMed ID: 30803854
[TBL] [Abstract][Full Text] [Related]
14. Enhanced efficacy of sublingual immunotherapy by liposome-mediated delivery of allergen.
Aliu H; Rask C; Brimnes J; Andresen TL
Int J Nanomedicine; 2017; 12():8377-8388. PubMed ID: 29200850
[TBL] [Abstract][Full Text] [Related]
15. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH
Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911
[TBL] [Abstract][Full Text] [Related]
16. Non-invasive delivery of nanoparticles to hair follicles: a perspective for transcutaneous immunization.
Mittal A; Raber AS; Schaefer UF; Weissmann S; Ebensen T; Schulze K; Guzmán CA; Lehr CM; Hansen S
Vaccine; 2013 Jul; 31(34):3442-51. PubMed ID: 23290836
[TBL] [Abstract][Full Text] [Related]
17. Polymer nanoparticles for enhanced immune response: combined delivery of tumor antigen and small interference RNA for immunosuppressive gene to dendritic cells.
Heo MB; Cho MY; Lim YT
Acta Biomater; 2014 May; 10(5):2169-76. PubMed ID: 24394635
[TBL] [Abstract][Full Text] [Related]
18. The Efficacy of Sublingual Immunotherapy for Allergic Rhinitis May Vary with the Time of Day.
Igarashi S; Suzuki K; Nakamura Y; Ishimaru K; Fukano C; Masuyama K; Ohashi-Doi K; Nakao A
Int Arch Allergy Immunol; 2016; 171(2):111-118. PubMed ID: 27902978
[TBL] [Abstract][Full Text] [Related]
19. Sublingual Immunotherapy Attenuates Nasal Symptoms Upon Allergen Exposure in Murine Allergic Rhinitis Model via an Induction of IL-10 producing T cells in Submandibular Lymph Node.
Qu Y; Yamada T; Aoi N; Morikura I; Fuchiwaki T; Hotta Y; Prokopakis E; Kawauchi H
Ann Otol Rhinol Laryngol; 2019 Jun; 128(6_suppl):26S-35S. PubMed ID: 31092040
[TBL] [Abstract][Full Text] [Related]
20. Glycosylation of OVA antigen-loaded PLGA nanoparticles enhances DC-targeting for cancer vaccination.
Chou PY; Lin SY; Wu YN; Shen CY; Sheu MT; Ho HO
J Control Release; 2022 Nov; 351():970-988. PubMed ID: 36220488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
